ClinicalTrials.gg
Drug

CORT118335 clinical trials

Also written CORT118335 and Miricorilant.

studies test it
15
open now
0
in phase 3
0
first study started
2017

How each study uses CORT118335 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Development codes

CORT118335
11

Other names

Miricorilant
7
Miricorilant 150 mg
1
Miricorilant 100 mg
1
Miricorilant 50 mg
1
Miricorilant 10 mg
1

Studies by the year they started

15 studies that test it; most in 2020 (3)

Studies that test CORT118335, by start year
YearStudies
20171
20181
20192
20203
20212
20221
20232
20252
20261

By phase

A phase 1/2 study counts in both.

Phase 1
10
Phase 2
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 14 · Other 1

Corcept Therapeutics (14) · The Scripps Research Institute (1)

Often tested with

Tested in the same studies.

Prednisone (1) · Glucose (1)

Studies

Open first, then newest update. How each study uses CORT118335 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 15